Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cholangiocarcinoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 231 Breast Neoplasms 131 Neoplasms 96 Prostatic Neoplasms 34 Fatigue 34 Obesity 24 Colorectal Neoplasms 22 Lung Neoplasms 20 Polycystic Ovary Syndrome 17 Ovarian Neoplasms 13 Colonic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Pancreatic Neoplasms 10 Multiple Myeloma 10 Lymphedema 10 Hematologic Neoplasms 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Leukemia 9 Cardiotoxicity 9 Insulin Resistance 8 Brain Neoplasms 8 Stomach Neoplasms 6 Peripheral Nervous System Diseases 6 Overweight 6 Cognitive Dysfunction 6 Cachexia 6

Interventions

Gemcitabine 108 Cisplatin 73 Oxaliplatin 43 pembrolizumab 33 Fluorouracil 31 Capecitabine 30 durvalumab 26 Leucovorin 25 lenvatinib 23 Magnetic Resonance Spectroscopy 14 Irinotecan 13 Nivolumab 12 Albumin-Bound Paclitaxel 12 Specimen Handling 11 Radiofrequency Ablation 11 Drug Therapy 11 Biopsy 11 tislelizumab 10 pemigatinib 10 apatinib 10 Taxes 10 Floxuridine 10 130-nm albumin-bound paclitaxel 10 Radiotherapy 9 Bevacizumab 9 Carboplatin 8 tremelimumab 7 atezolizumab 7 Platinum 7 Photochemotherapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02162914 2020-07-31

REACHIN

Erasme University Hospital

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡